Please join the Ontario Institute for Cancer Research (OICR) and the University of Toronto Department of Chemistry for the:

Dr. Mark Ernsting Drug Discovery Memorial Lecture
Friday, January 27, 2023 from 10 – 11 a.m. ET
Lash Miller Chemical Laboratories, 80 St. George Street, Rm LM 158
Or via Zoom (link to be sent after registration)

This lecture is named in honour of Dr. Mark Ernsting who was a Senior Biomedical Engineer in the Drug Discovery Program at OICR. Dr. Ernsting passed away in December 2015. He was a brilliant and passionate scientist as well as a great colleague and friend. Dr. Ernsting endeavoured to improve the lives of cancer patients by developing nanomedicines.

This year’s lecture titled ²²⁵Ac-Based Targeted Alpha Therapies (TATs): Research to Clinical Trials will be delivered by Dr. John Valliant, Founder and Chief Executive Officer of Fusion Pharmaceuticals and a Professor in the Department of Chemistry and Chemical Biology at McMaster University.

Jesse Gillis, Associate Professor, Physiology, University of Toronto

–

More details at TorBUG – https://torbug.org/

Tanya Berardini, Chief Scientific Officer, Phoenix Bioinformatics

More details at TorBUG – https://torbug.org/

Sushmita Roy, Associate Professor, Biostatistics and Medical Informatics, University of Wisconsin-Madison

More details at TorBUG – https://torbug.org/

Maggie Crow, Senior Scientist, Genentech

More details at TorBUG – https://torbug.org/